溶瘤病毒
癌症
癌症治疗
免疫系统
免疫疗法
癌细胞
癌症干细胞
医学
癌症治疗
旁观者效应
移植
自杀基因
癌症免疫疗法
癌症研究
遗传增强
生物
免疫学
基因
内科学
生物化学
作者
Malikeh Rad Niknam,Farnoosh Attari
出处
期刊:Current stem cell research & therapy
[Bentham Science]
日期:2022-01-01
卷期号:17 (1): 26-42
被引量:2
标识
DOI:10.2174/1574888x16666210810100858
摘要
Scientists encounter many obstacles in traditional cancer therapies, including the side effects on the healthy cells, drug resistance, tumor relapse, the short half-life of employed drugs in the blood circulation, and the improper delivery of drugs toward the tumor site. The unique traits of stem cells (SCs) such as self-renewal, differentiation, tumor tropism, the release of bioactive molecules, and immunosuppression have opened a new window for utilizing SCs as a novel tool in cancer treatment. In this regard, engineered SCs can secrete anti-cancer proteins or express enzymes used in suicide gene therapy which locally induce apoptosis in neoplastic cells via the bystander effect. These cells also stand as proper candidates to serve as careers for drug-loaded nanoparticles or to play suitable hosts for oncolytic viruses. Moreover, they harbor great potential to be employed in immunotherapy and combination therapy. However, tactful strategies should be devised to allow easier transplantation and protection of SCs from in vivo immune responses. In spite of the great hope concerning SCs application in cancer therapy, there are shortcomings and challenges to be addressed. This review tends to elaborate on recent advances on the various applications of SCs in cancer therapy and existing challenges in this regard.
科研通智能强力驱动
Strongly Powered by AbleSci AI